Back to search
Diabetic Retinopathy (DR)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Diabetic Retinopathy (DR) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Diabetic Retinopathy (DR) trials you may qualify forThe objective of this study is to investigate the efficacy of implementing the AI-SaMD(VUNO Med®-Fundus AI™) alongside routine clinical practice for the detecti…
The study will evaluate whether videos can improve understanding of diabetic eye disease, and follow-up rates in the eye clinic.
The goal of this clinical trial is to see if treatment with faricimab or biosimilar ranibizumab leads to different early imaging changes in adults with diabetic…
This prospective interventional translational study aims to identify and validate protein biomarkers associated with major ophthalmological diseases, including…
The goal of this retrospective observational study is to evaluate the prevalence and severity of diabetic retinopathy (DR) and to identify associated risk facto…
The goal of this observational study is to understand whether vascular and structural changes in the eyes caused by diabetes can help predict which people are m…
This randomized controlled trial evaluates whether providing clinicians with AI-derived quantitative retinal information improves the quality and efficiency of…
The aim of the study is to evaluate in diabetic patients affected by diabetic retinopathy epivascular glia regression and macular pigment restoration after fari…